Patents for C12P 21 - Preparation of peptides or proteins (112,499)
04/2002
04/04/2002WO2002027012A1 Process for producing protein decomposition product
04/04/2002WO2002027008A1 Promoter sequences
04/04/2002WO2002027005A2 Enhanced transfection system
04/04/2002WO2002026998A2 Hydrolases
04/04/2002WO2002026988A2 Human drug metabolizing enzymes
04/04/2002WO2002026984A2 Potassium channel interactors and uses therefor
04/04/2002WO2002026982A2 Secreted human proteins
04/04/2002WO2002026963A1 Shingolipid ceramide deacylase gene
04/04/2002WO2002026961A2 Production process of surfactin
04/04/2002WO2002026951A2 Oxidoreductases
04/04/2002WO2002026950A2 Transferases
04/04/2002WO2002026937A1 Chemical substance for protection of brain nerve cell and method for producing thereof
04/04/2002WO2002026832A1 Antibodies for human cytochrome p450 2d6
04/04/2002WO2002026830A1 Method for producing human anti-thymocyte immunoglobulins
04/04/2002WO2002026825A2 G-protein coupled receptors
04/04/2002WO2002026822A2 Pumpcn compositions and uses thereof
04/04/2002WO2002026805A2 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002WO2002026772A1 Method for the selective modification of peptides and proteins
04/04/2002WO2002026257A1 Antibodies to the propeptide of candida albicans and methods of use
04/04/2002WO2002026256A1 Excessive antibody production inhibitors, process for producing the same and method of using the same
04/04/2002WO2002026250A2 Vaccines for proliferative ileitis
04/04/2002WO2002026193A2 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/04/2002WO2001094544A3 N.bstnbi nicking endonuclease and methods for using endonucleases in single-stranded displacement amplification
04/04/2002WO2001085980A3 Enzymatic assays for screening anti-cancer agents
04/04/2002WO2001075067A3 Novel nucleic acids and polypeptides
04/04/2002WO2001073034A3 Beta-like glycoprotein hormone polypeptide and heterodimer
04/04/2002WO2001073033A3 Anti-angiogenic and anti-tumor properties of matin and other laminin domains
04/04/2002WO2001072846A3 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof
04/04/2002WO2001072839A3 Human g-protein coupled receptors
04/04/2002WO2001072781A3 Human genes and expression products
04/04/2002WO2001071017A3 Modified nodavirus rna for gene delivery
04/04/2002WO2001068695A3 Factor-h related protein 5 (fhr-5) and antibodies thereto
04/04/2002WO2001066741A3 Kcnb: a novel potassium channel protein
04/04/2002WO2001062778A3 Tumour-specific animal proteins
04/04/2002WO2001055178A9 Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer
04/04/2002WO2001053353A3 Recombinant antibodies to human interkleukin-1 beta
04/04/2002WO2001053352A3 Sperm specific proteins
04/04/2002WO2001051616A3 Techniques for growth and differentiation of human pluripotent stem cells
04/04/2002WO2001049715A3 Methods and compositions for inhibiting neoplastic cell growth
04/04/2002WO2001034802A3 Compositions and methods for the therapy and diagnosis of prostate cancer
04/04/2002WO2000072021A3 Cancer associated antigens and uses therefor
04/04/2002WO2000064261A9 Role of vascular endothelial growth factor-b (vegf-b) in developing bones and uses thereof
04/04/2002US20020040484 Administering to cell a compound capable of modulating protein complex having a first protein which is delta -catenin interacting with a second protein which is FAK2
04/04/2002US20020040130 Polymorphic kinase anchor proteins and nucleic acids encoding the same
04/04/2002US20020040009 Novel ratA
04/04/2002US20020040000 Human kcnq5 potassium channel, methods and compositions thereof
04/04/2002US20020039991 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002US20020039789 Method for production of neuroblasts
04/04/2002US20020039763 Interferon-like protein Zcyto21
04/04/2002US20020039758 Fermentative production of valuable compounds on an industrial scale using chemically defined media
04/04/2002US20020039754 Monitoring and classifying the spread of cancer in humans; obtain biopsy of tissue, determine concentration of tumor suppressor protein, determine thrombospondin concentration, monitor vascularization, evaluate cell for tumor propagation
04/04/2002US20020039581 Antibodies against CTLA4 and uses therefor
04/04/2002US20020039580 Method for the high level expression of active lymphotoxin-beta receptor immunoglobulin chimeric proteins and their purification
04/04/2002DE10045591A1 Ortsspezifische, antikörpervermittelte Aktivierung proapoptotischer Zytokine - AMAIZe (Antibody-Mediated Apoptosis Inducing Zytokine) Site-specific, antibody-mediated activation of proapoptotic cytokines - Amaize (Antibody Mediated Apoptosis Inducing cytokines)
04/04/2002CA2423991A1 Pumpcn compositions and uses thereof
04/04/2002CA2423953A1 Hydrolases
04/04/2002CA2423797A1 Antibodies to the propeptide of candida albicans and methods of use
04/04/2002CA2423708A1 Method for producing human anti-thymocyte immunoglobulins
04/04/2002CA2423704A1 G-protein coupled receptors
04/04/2002CA2423701A1 Oxidoreductases
04/04/2002CA2423694A1 Transferases
04/04/2002CA2423588A1 Improved vaccines for proliferative ileitis and methods of making and using the same
04/04/2002CA2423446A1 Isolated human transporter proteins, nucleic acid molecules encoding human transporter proteins, and uses thereof
04/04/2002CA2423424A1 Secreted proteins
04/04/2002CA2423413A1 Use of cyr61 in the treatment and diagnosis of human uterine leiomyomas
04/04/2002CA2422530A1 Human drug metabolizing enzymes
04/04/2002CA2421680A1 Antibodies for human cytochrome p450 2d6
04/04/2002CA2421676A1 Method for the selective modification of peptides and proteins
04/04/2002CA2421620A1 Promoter sequences
04/04/2002CA2420960A1 Potassium channel interactors and uses therefor
04/04/2002CA2420415A1 Rapid profiling of the interactions between a chemical entity and proteins in a given proteome
04/03/2002EP1193271A2 Compositions and methods for protein structural determinations
04/03/2002EP1192280A1 Synthetic ligation reassembly in directed evolution
04/03/2002EP1192278A1 48 human secreted proteins
04/03/2002EP1192266A2 Complement-resistant non-mammalian dna viruses and uses thereof
04/03/2002EP1192263A1 Pichia methanolica glyceraldehyde-3-phosphate dehydrogenase 1 promoter and terminator
04/03/2002EP1192259A1 Tankyrase2 materials and methods
04/03/2002EP1192258A2 Human poly(adp-ribose) polymerase 2 materials and methods
04/03/2002EP1192257A2 Human regulators of intracellular phosphorylation
04/03/2002EP1192254A1 Helical polypeptide zalpha29
04/03/2002EP1192252A2 Secreted protein zacrp4
04/03/2002EP1192251A1 Human sel-10 polypeptides and polynucleotides that encode them
04/03/2002EP1192250A2 Human rna metabolism proteins (rmep)
04/03/2002EP1192249A1 47 human secreted proteins
04/03/2002EP1192247A1 Sphingosine kinase enzyme
04/03/2002EP1192242A1 Production of the lipidated form of the peptidoglycan-associated lipoproteins of gram-negative bacteria
04/03/2002EP1192176A1 49 human secreted proteins
04/03/2002EP1192171A1 48 human secreted proteins
04/03/2002EP1191940A1 Tumor necrosis factor receptor 5
04/03/2002EP1191839A1 Transgenic animals for producing specific isotypes of human antibodies via non-cognate switch regions
04/03/2002EP0934075B1 Micrococcin atibiotic for the prevention and treatment of mastitis
04/03/2002EP0775199B1 Superoxide dismutase-4
04/03/2002EP0754049B1 Anti-fungal methods and materials
04/03/2002EP0723536B1 An aglucone isoflavone enriched vegetable protein whey, whey protein, and process for producing
04/03/2002EP0722489B1 Monoclonal antibodies that recognize flk-2 receptors and the isolation of primitive hematopoietic stem cell populations
04/03/2002EP0666868B1 Use of anti-VEGF antibodies for the treatment of cancer
04/03/2002EP0605428B1 Hormone-secreting pancreatic cells maintained in long-term culture
04/03/2002CN1343253A Expression of proteolytic enzymes in koji mold in presence of carbon sources
04/03/2002CN1343221A Polypeptide variants with altered effector function
04/03/2002CN1343125A Immunostimulant bacterial membrane tractions in cancer treatment